Diligence memo · auto-generated · as of July 1, 2026
Alliedpath, Inc
Alliedpath, Inc looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Alliedpath, Inc operates in Biotechnology, based in SAN DIEGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Alliedpath, Inc has raised $640K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $490K on 2009-10-27.
Most recent recorded round closed around 2010-05-05.
Valuation (modeled)modeled
Provath models Alliedpath, Inc at approximately $8.3M (range $80K–$94M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.42× the median modeled value of Pre-Seed Biotechnology companies in 2010–2012 (132 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 6 months.
Last raise 16.2 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 3.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 13% of Biotechnology peers (4291 compared).
Modeled value ranks above 16% of those peers.
Closest niche peers: Iquum Inc, Olive Medical Corp, Hygeia Therapeutics, Inc., Act Biotech Inc, Microarrays, Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.